OPGEN

Headquartered in Rockville, Maryland, OpGen is a precision medicine company harnessing the power of molecular diagnostics to help combat infectious disease. Our innovative approaches to infectious disease diagnostics consists of highly multiplexed syndromic molecular panels to address the global threat of antimicrobial resistance (AMR), improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs). Together we improve patient care and fight AMR through cutting edge molecular microbiology... We harness the power of molecular microbiology to develop diagnostic solutions that will optimize the treatment of life-threatening, drug resistant infections. We seek to dramatically transform patient care to guide antibiotic therapy selection and help improve antibiotic stewardship... OpGen, along with its subsidiaries, Curetis Ares Genetics, develops commercializes molecular microbiology solutions.

Also known as: OpGen Inc.

Primary location: Clarksburg United States